FDA Adverse Event Injury Summary report: N

ASCENT CLSD BOX PS FMRL LG R

MDR report key: 7801041 · Received August 21, 2018

Report

Report Number
0001825034-2018-04744
Event Type
Injury
Date Received
August 21, 2018
Date of Event
July 19, 2018
Report Date
March 5, 2019
Manufacturer
ZIMMER BIOMET, INC.
Product Code
JWH
PMA / PMN Number
K993111
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY UPDATED AND ADDITIONAL INFORMATION. MEDICAL PRODUCTS: ASCENT CLSD BOX PS FMRL; P/N: 178044, L/N: 909580. POROUS FINN STEM; P/N: CP111992, L/N: 821130. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034 - 2019 - 00799.

Description of Event or Problem · 0

IT WAS REPORTED THE PATIENT HAD A REVISION PROCEDURE 15 YEARS POST IMPLANTATION DUE TO FEMORAL DISASSOCIATION FOR STEM JUNCTION FAILURE.ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION HAVE BEEN MADE; HOWEVER, NO MORE IS AVAILABLE.

Additional Manufacturer Narrative · 1

ZIMMER BIOMET COMPLAINT NUMBER (B)(4). CUSTOMER HAS INDICATED THAT THE PRODUCT IS IN PROCESS OF BEING RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. PRODUCT LOCATION IS UNKNOWN.

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT UNDERWENT A RIGHT KNEE ARTHROPLASTY ON AN UNKNOWN DATE. THE PATIENT IS SCHEDULED TO UNDERGO A REVISION ON AN UNKNOWN DATE DUE TO WEAR. NO ADDITIONAL PATIENT CONSEQUENCES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
644632 ASCENT CLSD BOX PS FMRL LG R PROSTHESIS, KNEE JWH ZIMMER BIOMET, INC. N/A 909580

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R